Publication

Remodeling of O Antigen in Mucoid Pseudomonas aeruginosa via Transcriptional Repression of wzz2

Downloadable Content

Persistent URL
Last modified
  • 05/22/2025
Type of Material
Authors
    Ashley R. Cross, Emory UniversityJoanna B. Goldberg, Emory UniversityE. Peter Greenberg, University of Washington
Language
  • English
Date
  • 2019-01-01
Publisher
  • American Society for Microbiology: Open Access Journals
Publication Version
Copyright Statement
  • © 2019 Cross and Goldberg.
License
Final Published Version (URL)
Title of Journal or Parent Work
ISSN
  • 2150-7511
Volume
  • 10
Issue
  • 1
Start Page
  • e02914
End Page
  • 18
Grant/Funding Information
  • Additional funding was awarded by the NIH and the CFF to J.B.G. under award numbers R21AI122192 and GOLDBE16G0, respectively.
  • The National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) under award number F31AI136310 also supported A.R.C.
  • This work was partially supported by a predoctoral fellowship to A.R.C. from the Cystic Fibrosis Foundation (CFF)-funded CF@LANTA RDP Center (MCCART15R0), CF-AIR, components of the Emory+Children’s CF Center of Excellence at Emory University, and Children’s Healthcare of Atlanta.
Supplemental Material (URL)
Abstract
  • Pseudomonas aeruginosa is an opportunistic pathogen that causes chronic lung infections in people with cystic fibrosis (CF). Chronic P. aeruginosa isolates generally do not express O antigen and often have a mucoid phenotype, which is characterized by the overproduction of the exopolysaccharide alginate. Therefore, O antigen expression and the mucoid phenotype may be coordinately regulated upon chronic adaption to the CF lung. Here we demonstrate that PDO300, a mucoid strain derived from the nonmucoid laboratory isolate PAO1, does not produce very long O antigen due to decreased expression of Wzz2, the very long O antigen chain length control protein, and that mucoid clinical isolates express reduced levels of Wzz2 compared to nonmucoid isolates. Further, we show that forcing the expression of very long O antigen by PDO300, by providing wzz2 in trans, does not alter alginate production, suggesting that sugar precursors are not limited between the two biosynthesis pathways. Moreover, we confirm that AmrZ, a transcription factor highly expressed in mucoid strains, is a negative regulator of wzz2 promoter activity and very long O antigen expression. These experiments identify the first transcriptional regulator of O antigen chain length in P. aeruginosa and support a model where transition to a chronic mucoid phenotype is correlated with downregulation of very long O antigen through decreased Wzz2 production. IMPORTANCE Detection of mucoid Pseudomonas aeruginosa, characterized by the overproduction of alginate, is correlated with the establishment of a chronic pulmonary infection and disease progression in people with cystic fibrosis (CF). In addition to the overproduction of alginate, loss of O antigen lipopolysaccharide production is also selected for in chronic infection isolates. In this study, we have identified the regulatory network that inversely regulates O antigen and alginate production. Understanding the regulation of these chronic phenotypes will elucidate mechanisms that are important for the establishment of a long-term P. aeruginosa lung infection and ultimately provide an opportunity for intervention. Preventing P. aeruginosa from chronically adapting to the CF lung environment could provide a better outcome for people who are infected.
Author Notes
Keywords
Research Categories
  • Health Sciences, Pathology
  • Biology, Genetics

Tools

Relations

In Collection:

Items